Could J&J’s combination treatment for PAH bridge the gaps between guidelines and practice, while easing the burden on patients?

The burden on clinical trials designers and healthcare professionals can only be eased by fixing a broken process: trial feasibility.

The world is taking more interest in clinical trials. How are clinical trials adapting? Regeneron’s Bari Kowal keeps us updated.

Developing modified release formulations can be complex – but a translational pharmaceutics approach can smooth the path

If we can edit RNA at the kilobase scale, we can treat more diseases at the genetic level

Our annual Innovation Awards celebrate the top launches of the year for drug development and manufacturing technology.

How pharmaceutical companies are aligning their sustainability goals with the complexities of the modern supply chain

How a new collaboration looks to improve analytical testing for mRNA products.

Drug developers place their bets on the ROR-1 antigen in the battle against solid tumors.

Counterfeit deterrents are not yet available in some regions. We speak with Advanco CEO Alf Goebel to find out why.